Nicardipine hydrochlorideNicardipine hydrochloride
MedChemExpress (MCE)
HY-12515A
54527-84-3
YC-93
99.73%
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months
-20°C, 1 month (sealed storage, away from moisture and light)
Room temperature in continental US
may vary elsewhere.
Nicardipine hydrochloride (YC-93) is a calcium channel blocker with an IC50 of 1 μM for blocking cardiac calcium channels. Nicardipine hydrochloride acts as an agent for chronic stable angina and for controlling blood pressure.
Nicardipine (0.1-10 μM
24-48 h) reduces viability and proliferation of vascular smooth muscle cells (VSMCs) and inhibits their ability to migrate[2].
Nicardipine (0.3-10 mg/kg
p.o.) shows antihypertensive properties[3]. LD50s of Nicardipine are 643 mg/kg (oral) and 557 mg/kg (oral)
18.1 mg/kg (intravenous) 25.0 mg/kg (intravenous)
735 mg/kg (subcutaneous) and 683 mg/kg (subcutaneous)
171 mg/kg (intraperitoneally) and 155 mg/kg (intraperitoneally) for male and female Sprague-Dawley rats, respectively[3]. LD50s of Nicardipine are 187 mg/kg (oral) and 15.5 mg/kg (intravenous) for male Wistar rats, respectively[3]. LD50s of Nicardipine are 634 mg/kg (oral) and 650 mg/kg (oral)
20.7 mg/kg (intravenous) 19.9 mg/kg (intravenous)
540 mg/kg (subcutaneous) and 710 mg/kg (subcutaneous)
144 mg/kg (intraperitoneally) and 161 mg/kg (intraperitoneally) for male and female mice, respectively[3].
IC50: 1 μM (cardiac calcium channels)[1] In Vitro Nicardipine (0.1-10 μM
24-48 h) reduces viability and proliferation of vascular smooth muscle cells (VSMCs) and inhibits their ability to migrate[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Nicardipine hydrochloride Related Antibodies Cell Viability Assay[2] Cell Line: VSMCs were isolated from New Zealand rabbit aortic preparations
| | | |
| | | | | |
[1]. Charnet P, et al. Electrophysiological analysis of the action of nifedipine and nicardipine on myocardial fibers. Fundam Clin Pharmacol. 1987
1(6):413-31. [Content Brief]
[2]. R Stamatiou, et al. The dihydropyridine calcium antagonist nicardipine reduces aortic smooth muscle cell viability, proliferation and migration. Cardiovascular Research, 2018 Apr,114(1):S43.
[3]. Sherrin H. Baky. Nic ardipine Hydrochloride.